Literature DB >> 69613

Immunization with R mutants of Salmonella minnesota. II. Serological response to lipid A and the lipopolysaccharide of Re mutants.

M A Johns, S C Bruins, W R McCabe.   

Abstract

Rabbits were immunized with Salmonella minnesota Re mutant bacilli or lipid A, and the serological responses were compared. Re lipopolysaccharide and lipid A were found to possess distinct antigenic determinants as measured by hemagglutination, hemolysis, and precipitin techniques. Lipid A preparations from several enterobacterial and non-enterobacterial species were shown to cross-react in agar gel precipitation reactions. In contrast, preparations from bacilli that do not contain glucosamine as an integral part of their lipid A structure did not demonstrate cross-reactivity with enterobacterial lipid A. Antibody to smooth heterologous bacilli present in some antisera prepared against Re bacilli or lipid A was directed specifically against the smooth lipopolysaccharide and not against the Re or lipid A determinants, demonstrating a nonspecific mitogenic response. Precipitation and immunofluorescence tests indicated that the Re determinant was available on smooth bacilli for reactions with specific antisera but that the lipid A determinant was not.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 69613      PMCID: PMC421074          DOI: 10.1128/iai.17.1.9-15.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  15 in total

1.  Biological activities of lipid A complexed with bovine-serum albumin.

Authors:  C Galanos; E T Rietschel; O Lüderitz; O Westphal; Y B Kim; D W Watson
Journal:  Eur J Biochem       Date:  1972-12-04

2.  Biological properties of lipid A from Shigella sonnei.

Authors:  C Lugowski; E Romanowska
Journal:  Eur J Biochem       Date:  1974-10-01

3.  Protection against gram-negative infections with antiserum to lipid A from Salmonella minnesota R595.

Authors:  N A Mullan; P M Newsome; P G Cunnington; G H Palmer; M E Wilson
Journal:  Infect Immun       Date:  1974-12       Impact factor: 3.441

4.  Biochemical studies on lipopolysaccharides of Salmonella R mutants. 6. Investigations on the structure of the lipid A component.

Authors:  J Gmeiner; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-01

5.  Common enterobacterial antigen. I. Isolation and purification from Salmonella typhose 0:901.

Authors:  M A Johns; R E Whiteside; E E Baker; W R McCabe
Journal:  J Immunol       Date:  1973-03       Impact factor: 5.422

6.  Interaction of lipopolysaccharides and lipid A with complement.

Authors:  C Galanos; E T Rietschel; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-03-01

7.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

8.  Precipitating antibody against core glycolipid of Enterobacteriaceae.

Authors:  L S Young; P R Stevens
Journal:  Experientia       Date:  1974-02-15

9.  Immunization with R mutants of S. Minnesota. I. Protection against challenge with heterologous gram-negative bacilli.

Authors:  W R McCabe
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

10.  Identification of a 2, 3-diamino-2, 3-dideoxyhexose in the lipid A component of lipopolysaccharides of Rhodopseudomonas viridis and Rhodopseudomonas palustris.

Authors:  J Roppel; H Mayer
Journal:  Carbohydr Res       Date:  1975-03       Impact factor: 2.104

View more
  25 in total

Review 1.  Bloodstream infections: epidemiology, pathophysiology and therapeutic perspectives.

Authors:  R Salomão; O Rigato; A C Pignatari; M A Freudenberg; C Galanos
Journal:  Infection       Date:  1999 Jan-Feb       Impact factor: 3.553

2.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

Review 3.  Immunotherapeutic advances in the treatment of gram-negative bacterial sepsis.

Authors:  D L Dunn
Journal:  World J Surg       Date:  1987-04       Impact factor: 3.352

4.  Mechanisms of lipopolysaccharide-initiated rabbit platelet responses: alternative complement pathway dependence of the lytic response.

Authors:  D C Morrison; L F Kline; Z G Oades; P M Henson
Journal:  Infect Immun       Date:  1978-06       Impact factor: 3.441

5.  Induction of immunity against lethal Haemophilus influenzae type b infection by Escherichia coli core lipopolysaccharide.

Authors:  M I Marks; E J Ziegler; H Douglas; L B Corbeil; A I Braude
Journal:  J Clin Invest       Date:  1982-04       Impact factor: 14.808

6.  alpha-GlcNAc-1-->2-alpha-glc, the Salmonella homologue of a conserved lipopolysaccharide motif in the Enterobacteriaceae, elicits broadly cross-reactive antibodies.

Authors:  N A Nnalue
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Lipid A and anti-lipid A.

Authors:  I Mattsby-Baltzer; B Kaijser
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

8.  Antibody specific for Escherichia coli J5 cross-reacts to various degrees with an Escherichia coli clinical isolate grown for different lengths of time.

Authors:  D E McCallus; N L Norcross
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

9.  Lipid A in anaerobic bacteria.

Authors:  G Dahlén; I Mattsby-Baltzer
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

10.  Isolation and characterization of murine monoclonal antibodies specific for gram-negative bacterial lipopolysaccharide: association of cross-genus reactivity with lipid A specificity.

Authors:  W C Bogard; D L Dunn; K Abernethy; C Kilgarriff; P C Kung
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.